252 related articles for article (PubMed ID: 16878852)
1. Intravenous immunoglobulin use for neurologic diseases.
Koski CL; Patterson JV
J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
[TBL] [Abstract][Full Text] [Related]
2. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
Molnár MJ
Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
[TBL] [Abstract][Full Text] [Related]
3. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of intravenous immunoglobulins in neurology.
Hughes RA; Dalakas MC; Cornblath DR; Latov N; Weksler ME; Relkin N
Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):34-42. PubMed ID: 19883422
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin Treatment in Neuromuscular Medicine.
Burakgazi AZ
J Clin Neuromuscul Dis; 2019 Jun; 20(4):182-193. PubMed ID: 31135621
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
7. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
8. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
[TBL] [Abstract][Full Text] [Related]
9. Advances in the use of IVIg in neurological disorders.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():1-2. PubMed ID: 18685918
[No Abstract] [Full Text] [Related]
10. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
11. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I
J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
[TBL] [Abstract][Full Text] [Related]
12. Using immunoglobulins in muscular disease treatment.
Pul R; Stangel M
Expert Opin Biol Ther; 2008 Aug; 8(8):1143-50. PubMed ID: 18613765
[TBL] [Abstract][Full Text] [Related]
13. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
14. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Stangel M; Gold R
Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous immunoglobulins in neurology].
Vuillemet F; Tranchant C; Warter JM
Presse Med; 1993 Nov; 22(34):1741-4. PubMed ID: 8302781
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis and myasthenic syndrome.
Antozzi C
Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
[TBL] [Abstract][Full Text] [Related]
17. Significant dermatological side effects of intravenous immunoglobulin.
Hurelbrink CB; Spies JM; Yiannikas C
J Clin Neurosci; 2013 Aug; 20(8):1114-6. PubMed ID: 23659929
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic apheresis in neurological disorders.
Weinstein R
J Clin Apher; 2000; 15(1-2):74-128. PubMed ID: 10767052
[No Abstract] [Full Text] [Related]
19. Current treatment of neuromuscular diseases.
Kokontis L; Gutmann L
Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
[No Abstract] [Full Text] [Related]
20. Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Lünemann JD; Quast I; Dalakas MC
Neurotherapeutics; 2016 Jan; 13(1):34-46. PubMed ID: 26400261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
